{
    "2018-01-31": [
        [
            {
                "time": "2023-02-01",
                "original_text": "明日最具爆发力六大牛股（2月1日）",
                "features": {
                    "keywords": [
                        "牛股",
                        "爆发力"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-02-01",
                "original_text": "医疗保健：从PE到DCF",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "PE",
                        "DCF"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-01",
                "original_text": "贝达药业：利润受研发支出等因素制约",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "利润",
                        "研发支出"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-02-01",
                "original_text": "99股获券商买入评级，酒鬼酒目标涨幅达87.14%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "酒鬼酒",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-02-01",
                "original_text": "[增持评级] 贝达药业(300558)业绩预告点评：业绩符合预期 埃克替尼销量大幅增长",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "业绩预告",
                        "埃克替尼",
                        "销量增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}